CRAC channel inhibition or knockdown of ORAI1 suppressed Blimp-1 expression and decreased the differentiation of IgG-producing plasma cells, which is in consistent with the previous study that CRAC inhibitors attenuate the function of B cells from patients with RA (50). Here, PRDM1 is linked to rheumatoid arthritis.